LataMed AI Corp. Initiates Preliminary Due Diligence for Expansion into Colombia

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that management has commenced preliminary due diligence and strategic planning for the company’s planned expansion into Colombia. The initiative is part of LataMed’s broader Latin American growth strategy, which aims to deploy its telehealth infrastructure, healthcare analytics, and care coordination solutions in emerging markets.

The initial phase involves evaluating corporate, regulatory, legal, operational, and commercial requirements for establishing a Colombian operating subsidiary. This assessment will include corporate formation, regulatory compliance, healthcare technology implementation, and potential strategic partnerships. The company believes Colombia represents a significant long-term opportunity to expand access to digital healthcare services, including telehealth, insurance accessibility, pharmacy integration, and AI-driven technologies.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “Colombia represents an important strategic opportunity as we continue executing our long-term vision of building an integrated digital healthcare ecosystem across Latin America. While we remain in the early stages of evaluating market entry requirements, we believe it is important to establish the proper legal, operational, and strategic foundation before expanding into new jurisdictions.”

The expansion into Colombia is part of LataMed’s focus on underserved and developing markets, where digital healthcare infrastructure can improve patient engagement and healthcare delivery. The company’s strategy centers on developing technology platforms for provider coordination, emergency medical response, and data-driven operations. Management emphasized that the initiative remains in the preliminary planning stage and that further updates will be provided as material developments occur.

LataMed AI Corp. is listed on the OTC market under the symbol LMED and is focused on building telehealth and AI-enabled solutions for emerging markets, with an initial regional focus on Latin America. For more information, visit the company’s website at https://latamed.ai or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.

The company cautioned that forward-looking statements in the announcement are subject to risks and uncertainties, including the ability to obtain financing, regulatory approvals, and successful operational execution in emerging markets. Investors are advised to consider these factors before making investment decisions.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is LataMed AI Corp. Initiates Preliminary Due Diligence for Expansion into Colombia.

The post LataMed AI Corp. Initiates Preliminary Due Diligence for Expansion into Colombia appeared first on citybuzz.